HCPCS J9347 — Inj, tremelimumab-actl, 1 mg (2026 RVU Values)

HCPCS code J9347 (Inj, tremelimumab-actl, 1 mg) is published in the 2026 CMS Physician Fee Schedule. Use this page as a reference for billing, productivity tracking, and compensation modeling.

Related references

• Add HCPCS J9347 to the RVU calculator
• Search additional codes